Comparative insulinogenic effects of glucose, arginine and glucagon in patients with diabetes mellitus, endocrine disorders and liver disease.
D000293:Adolescent; D000328:Adult; D001120:Arginine / Q000494:pharmacology; D003480:Cushing Syndrome / Q000503:physiopathology; D003920:Diabetes Mellitus / Q000503:physiopathology*; D004700:Endocrine System Diseases / Q000503:physiopathology*; D005260:Female; D005934:Glucagon / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D006505:Hepatitis / Q000503:physiopathology*; D006801:Humans; D006980:Hyperthyroidism / Q000503:physiopathology; D007037:Hypothyroidism / Q000503:physiopathology; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010673:Pheochromocytoma / Q000503:physiopathology
D007328:Insulin; D005934:Glucagon; D001120:Arginine; D005947:Glucose